Moreover, specific antisense oligonucleotide (ASO) of Linc00673-V3 (ASO-Linc00673-V3) has been designed to explore the potential role of Linc00673-V3 as a therapeutic target in NSCLC. This evidence concerns the gene LINC00511 and non-small cell lung carcinoma.